As of the latest SEC filings, Beam Therapeutics Inc. (BEAM) is held by 231 institutional funds. The largest fund shareholder is ARK Innovation ETF (ARKK), holding an estimated $198,306,760.32 in market value, representing 3.06% of its portfolio.
Funds holding Beam Therapeutics Inc. (BEAM)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BEAM
- CIK:
- 0001745999
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
ETF | Independent / Boutique | 3.06% | $198,306,760.32 | 6,538,304 | Apr 30, 2026 | Jun 23, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.11% | $91,655,999.20 | 3,220,520 | Feb 28, 2026 | Apr 24, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.04% | $77,414,757.58 | 3,248,626 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $73,802,701.50 | 3,097,050 | Mar 31, 2026 | May 28, 2026 |
|
ARKG
ARK Genomic Revolution ETF
|
ETF | Independent / Boutique | 5.43% | $67,094,600.49 | 2,212,153 | Apr 30, 2026 | Jun 23, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.08% | $55,726,693.30 | 2,338,510 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.03% | $53,223,184.99 | 2,233,453 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.08% | $29,760,548.27 | 1,248,869 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.09% | $28,686,720.60 | 945,820 | Apr 30, 2026 | Jun 26, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.11% | $26,331,192.00 | 925,200 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $26,232,826.56 | 1,100,832 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.24% | $26,069,829.36 | 1,093,992 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.12% | $25,087,461.54 | 881,499 | Feb 28, 2026 | Apr 24, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.15% | $18,513,479.34 | 776,898 | Mar 31, 2026 | May 28, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.22% | $18,076,008.20 | 758,540 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.20% | $16,493,314.92 | 692,124 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.04% | $14,751,757.18 | 518,333 | Feb 28, 2026 | Apr 24, 2026 |
|
-
ARK Venture Fund
|
CEF | Independent / Boutique | 1.67% | $14,440,022.01 | 476,097 | Apr 30, 2026 | Jun 23, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.07% | $13,700,587.08 | 481,398 | Feb 28, 2026 | Apr 24, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.07% | $13,482,048.96 | 444,512 | Apr 30, 2026 | Jun 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.09% | $13,481,160.48 | 473,688 | Feb 28, 2026 | Apr 28, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.01% | $12,149,517.08 | 426,898 | Feb 28, 2026 | Apr 24, 2026 |
|
FPHAX
Select Pharmaceuticals Portfolio
|
MF | Fidelity | 0.78% | $11,822,284.00 | 415,400 | Feb 28, 2026 | Apr 24, 2026 |
|
FDCAX
Fidelity Capital Appreciation Fund
|
MF | Fidelity | 0.14% | $11,031,021.00 | 363,700 | Apr 30, 2026 | Jun 26, 2026 |
|
DFSCX
U.S. MICRO CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.13% | $9,879,542.55 | 325,735 | Apr 30, 2026 | Jun 24, 2026 |
Advertisement (320x50)